UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(D) OF THE ~~SECURITIES EXCHANGE ACT OF 1934~~

~~Date~~SECURITIES ofEXCHANGE ~~Report~~ACT ~~(Date~~OF ~~of earliest event reported) November 24, 2016~~1934

~~NOVAGEN~~Date ~~INGENIUM~~of ~~INC~~Report (~~Exact~~date ~~name~~ of ~~registrant~~earliest asevent ~~specified~~reported) inJune ~~its~~19, ~~charter)~~2017

Nevada		333-149617		98-0471927
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

NOVAGEN INGENIUM, INC.

(Exact name of registrant as specified in its charter)

1846 Innovation Park Drive, Oro Valley, Arizona	85755
NEVADA	333-141617	98-0471927
(Address of principal executive offices)	(Zip Code)
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)

1846 E. Innovation Park Drive, Oro Valley, Arizona		85755
(Address of principal executive offices)		(Zip Code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 51.0201 ~~Departure~~Entry ofinto ~~Directors~~a orMaterial ~~Certain~~Definitive ~~Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers~~Agreement

~~On November 22, 2016, Dr. Jon N. Leonard resigned as a director of Novagen Ingenium Inc.~~ (~~the “Registrant”~~a). ~~Mr.~~AGREEMENT ~~Leonard~~FOR ~~advised~~SALE ~~the~~& ~~Registrant~~PURCHASE ~~that~~OF heSHARES ~~was resigning for personal reasons and not because of any disagreement with the Registrant or its management.~~

~~Item~~On 7June 19, 2017, the registrant, Novagen Ingenium Inc, a Nevada corporation (“Novagen”) entered into an Agreement for Sale & Purchase of Shares (the “Agreement for Sale & Purchase Of Shares”) under which the shareholders of Syndicated Transport and Trucking Pty Ltd (the “Syndicated Shareholders”) agree to sell to Novagen all the issued and outstanding shares of Syndicated Transport and Trucking Pty Ltd in exchange for 6,000,000 shares of Novagen common stock at a deemed price of AUD$0.0114 ~~Regulation~~per FDshare. ~~Disclosure~~Shares of Novagen’s common stock are quoted under the symbol “NOVZ” on the OTC Pink operated by OTC Markets Group, Inc. The total value of Syndicated Transport and Trucking Pty Ltd for the purposes of the Agreement for Sale & Purchase of Shares was determined by negotiation between the Syndicated Shareholders and Novagen to be AUD$840,000.

OnThe ~~November~~description ~~22,~~of ~~2016,~~the terms and conditions of the ~~Registrant~~Agreement ~~issued~~for aSale ~~press~~& ~~release~~Purchase of Shares set forth herein does not purport to be complete and is qualified in ~~the~~its ~~form~~entirety ~~attached~~by reference to ~~this~~the ~~Current~~terms ~~Report~~of onthe ~~Form~~Agreement ~~8-K~~for Sale & Purchase of Shares, which is filed as Exhibit 9910.1 ~~(the~~to ~~“Press~~this ~~Release”)~~Current Report.

The information inset forth under Item 71.01 of this Current Report onis ~~Form 8-K, including the Press Release, shall not be deemed “filed” for any purpose and shall not be deemed~~ incorporated herein by reference ~~into any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, regardless of any general incorporation language in such filing~~.

Item 9.01 Financial Statements and Exhibits

(db) Exhibits

9910.1 ~~Press~~Agreement ~~release~~for ofSale & Purchase Of Shares dated June 19, 2017 between Syndicated Shareholders and Novagen Ingenium, Inc.

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	NOVAGEN INGENIUM INC.
Date: November 24, 2016	By:	/s/ Micheal Nugent
Date: June 19, 2017	By:	/s/ Micheal Nugent
		Micheal Nugent
		President & CEO

Filing Compare · Novagen Ingenium Inc.